Chardan Capital Recent News
5 Reasons Arrowhead Pharma Is A Hepatitis B Leader
Why Regeneron's Praluent Is Likely To Be Removed From The U.S. Market This Year
Digital Ally Falls 5% After Big Earnings Miss
Guidance Cut Could Sent Ambarella's Downward Spiral Lower
Chardan Upgrades Regeneron Amid Relative Underperformance To Amgen Shares
Chardan Is Buying CEVA, Low End Smartphone/LTE Upgrade Cycles In China & India Offer 'Tremendous Opportunity'
Chardan Initiates Eyegate Pharma At Buy, Sets $6 Target
Chardan Thinks CalAmp Stock Is A Buy
Chardan Capital Initiates Signal Genetics At Buy
Avalanche Biotechnologies Buried By Disappointing Data, Downgrades
Chardan Capital Initiates Lion Biotechnologies With Buy
Chardan Capital Initiates UniQure At Buy
Analyst Discounts Chances For OHR Pharmaceutical Eye Drug
Chardan Capital Initiates Avalanche Biotechnologies With Neutral
Chardan Capital Initiates Ophthotech At Buy